RxDoctor Payments Data

Vahe Panossian

Neuromusculoskeletal Medicine, Sports Medicine · Pasadena, CANPI 1255359964

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $16,800 of the $17,536 with a category attached, or 95.8%. Advanced Orthopaedic Solutions, Inc. accounts for 97.0% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $10,551 and has fallen 98.7% since, to $137 in 2024. Among neuromusculoskeletal medicine, sports medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$17,536in general payments, 2019–2025

Across 16 payments — averaging $1095.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Advanced Orthopaedic Solutions, Inc.$17K
  • Arthrex$300
  • Conmed Corporation$116
  • Johnson & Johnson$44
  • Abbott$25
  • Lima USA, Inc.$21
  • plus $21 from 1 others

What the payments were for

  • Consulting fees$3002%
  • Speaking & faculty fees$16,80096%
  • Food & beverage$4362%

General payments by program year

19
20
21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,536 in reported general payments places this provider in the 95th percentile of 28 neuromusculoskeletal medicine, sports medicine providers in California.

See all neuromusculoskeletal medicine, sports medicine providers in California

Medicare billing

Part B allowed, 2024
$223,921
Medicare patients
403
Services billed
5,771

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban13$5,581
Ibuprofen119$702
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen33$614
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen51$495
Acetaminophen-CodeineAcetaminophen With Codeine46$466
Gabapentin27$183
Tramadol Hcl23$45

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$44$5,58113 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 28 neuromusculoskeletal medicine, sports medicine providers in California.

Other neuromusculoskeletal medicine, sports medicine in Pasadena

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →